Catherine Burns
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Catherine Burns has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Monique F. Kilkenny
Stroke and Ageing Research, School of Clinical Sciences at Monash Health, and Victorian Heart Institute, Monash University, Clayton, Australia (L.L.D., M.F.K.).
13 shared publications - Dominique A. Cadilhac
Stroke and Critical Care, Research, the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Heidelberg, Australia
11 shared publications - Tara Purvis
Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia
9 shared publications - Muideen T. Olaiya
Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health Monash University Clayton Victoria Australia
7 shared publications - Lachlan L. Dalli
Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health Monash University Clayton Victoria Australia
6 shared publications - Mark Raymond Nelson
School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
6 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 10, e89358
A Massive Open Online Course for Primary Prevention of Stroke: Evaluation of Co-Design Process
Background: Public awareness and understanding of stroke are crucial to reducing its overall burden. Massive open online courses (MOOCs) are free, self-directed online learning platforms that provide accessible education. Objective: This study aimed to describe the process, outcomes, and evaluation of co-designing the Preventing Stroke MOOC. Methods: The co-design process was conducted with various stakeholder groups from July 2020 to December 2024 in Australia over three phases: (1) predesign, (2) co-design, and (3) postdesign. In the predesign phase, we consulted with MOOC researchers and held a half-day in-person workshop with community members to prioritize the stroke prevention topics, structure, format, and features, followed by user testing of a single developed module. The larger study comprised 16 virtual focus groups (14 co-design and 2 user testing focus groups) with community members and health knowledge experts. Of the 14 co-design focus groups, 12 informed the MOOC design, including content, structure, and delivery. This was followed by drafting content for each module, expert review (eg, clinicians and researchers), and development of platform materials. In the postdesign phase, we conducted user testing to collect feedback and evaluated the co-design process to determine how participants’ input shaped the final MOOC design. Results: In the predesign phase, 5 MOOC experts and community members contributed to a pilot module comprising 9 pages on the prioritized topics, including a focus on stories from people with lived experience of stroke. A total of 8 people tested this module, providing positive feedback about content and delivery. The co-design phase engaged 22 participants across 12 focus groups relevant to the MOOC. Their suggestions contributed to the multimedia design of the 7 core modules, with personalization via 9 optional mini-modules. Feedback on technical issues and suggested improvements identified during postdesign user testing were resolved. Evaluation of the MOOC co-design process found that the majority of participants’ suggestions gathered during the co-design phase were included in the final MOOC. Conclusions: A structured, co-design process resulted in the Preventing Stroke MOOC reflecting participants’ suggestions and provided important insights on the educational information needed to inform the general population about stroke prevention.
- 20 October 2026
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 10, e89358
Open AccessA Massive Open Online Course for Primary Prevention of Stroke: Evaluation of Co-Design Process
Background: Public awareness and understanding of stroke are crucial to reducing its overall burden. Massive open online courses (MOOCs) are free, self-directed online learning platforms that provide accessible education. Objective: This study aimed to describe the process, outcomes, and evaluation of co-designing the Preventing Stroke MOOC. Methods: The co-design process was conducted with various stakeholder groups from July 2020 to December 2024 in Australia over three phases: (1) predesign, (2) co-design, and (3) postdesign. In the predesign phase, we consulted with MOOC researchers and held a half-day in-person workshop with community members to prioritize the stroke prevention topics, structure, format, and features, followed by user testing of a single developed module. The larger study comprised 16 virtual focus groups (14 co-design and 2 user testing focus groups) with community members and health knowledge experts. Of the 14 co-design focus groups, 12 informed the MOOC design, including content, structure, and delivery. This was followed by drafting content for each module, expert review (eg, clinicians and researchers), and development of platform materials. In the postdesign phase, we conducted user testing to collect feedback and evaluated the co-design process to determine how participants’ input shaped the final MOOC design. Results: In the predesign phase, 5 MOOC experts and community members contributed to a pilot module comprising 9 pages on the prioritized topics, including a focus on stories from people with lived experience of stroke. A total of 8 people tested this module, providing positive feedback about content and delivery. The co-design phase engaged 22 participants across 12 focus groups relevant to the MOOC. Their suggestions contributed to the multimedia design of the 7 core modules, with personalization via 9 optional mini-modules. Feedback on technical issues and suggested improvements identified during postdesign user testing were resolved. Evaluation of the MOOC co-design process found that the majority of participants’ suggestions gathered during the co-design phase were included in the final MOOC. Conclusions: A structured, co-design process resulted in the Preventing Stroke MOOC reflecting participants’ suggestions and provided important insights on the educational information needed to inform the general population about stroke prevention.
- Open Access
- 5 September 2026
- Published by SAGE Publications in Health Information Management Journal
Stroke clinical documentation education program in Australia and New Zealand
Background: Accurate and complete clinical documentation underpins the assignment of International Classification of Disease codes used for epidemiological research, hospital activity based funding, and health service planning. Objective: To develop, implement, and evaluate an education program for clinicians and clinical documentation specialists (CDS) to improve clinical documentation of stroke. Method: An education program to improve clinical documentation of stroke was developed by the Australia and New Zealand Stroke Coding Working Group. Eligible participants were clinicians (doctors, nurses, and allied health) and CDS in Australia or New Zealand. The education program comprised 4 modules in a pre-recorded 10-minute educational video. Surveys were administered before and after the educational video to evaluate knowledge (Kirkpatrick level 2) and obtain feedback. Quantitative data were summarised using descriptive statistics. Open-text responses to the feedback survey were analysed using inductive thematic analysis. Results: Among 72 eligible participants, 41 (57%) completed the pre- and post-educational knowledge assessment surveys ( n = 35 clinicians, n = 6 CDS). Compared with the pre-education survey, the median number of correct responses significantly increased in the post-education survey (pre: 3 [interquartile range (IQR) 2–4]; post: 5 [IQR 4–5]; p < 0.001). Most respondents (>90%) were satisfied with the education program, stating it provided “practical and transferrable knowledge” and that the education was “quick, clear, concise.” Conclusion: Our education program was associated with an increased knowledge of appropriate clinical documentation of stroke. Ongoing monitoring of clinical coding and clinical documentation is required to ascertain whether the education of the participants translates to improved clinical coding of stroke. Implications for health information management practice: Accurate and complete clinical documentation directly impacts clinical coding, which in turn affects reimbursement, patient safety, and data quality for epidemiological research, resource allocation, and health policy decision-making.
- 5 September 2026
- Published by SAGE Publications in Health Information Management Journal
Open AccessStroke clinical documentation education program in Australia and New Zealand
Background: Accurate and complete clinical documentation underpins the assignment of International Classification of Disease codes used for epidemiological research, hospital activity based funding, and health service planning. Objective: To develop, implement, and evaluate an education program for clinicians and clinical documentation specialists (CDS) to improve clinical documentation of stroke. Method: An education program to improve clinical documentation of stroke was developed by the Australia and New Zealand Stroke Coding Working Group. Eligible participants were clinicians (doctors, nurses, and allied health) and CDS in Australia or New Zealand. The education program comprised 4 modules in a pre-recorded 10-minute educational video. Surveys were administered before and after the educational video to evaluate knowledge (Kirkpatrick level 2) and obtain feedback. Quantitative data were summarised using descriptive statistics. Open-text responses to the feedback survey were analysed using inductive thematic analysis. Results: Among 72 eligible participants, 41 (57%) completed the pre- and post-educational knowledge assessment surveys ( n = 35 clinicians, n = 6 CDS). Compared with the pre-education survey, the median number of correct responses significantly increased in the post-education survey (pre: 3 [interquartile range (IQR) 2–4]; post: 5 [IQR 4–5]; p < 0.001). Most respondents (>90%) were satisfied with the education program, stating it provided “practical and transferrable knowledge” and that the education was “quick, clear, concise.” Conclusion: Our education program was associated with an increased knowledge of appropriate clinical documentation of stroke. Ongoing monitoring of clinical coding and clinical documentation is required to ascertain whether the education of the participants translates to improved clinical coding of stroke. Implications for health information management practice: Accurate and complete clinical documentation directly impacts clinical coding, which in turn affects reimbursement, patient safety, and data quality for epidemiological research, resource allocation, and health policy decision-making.
- Open Access
- 26 August 2026
- Published by S. Karger AG in Neuroepidemiology
- p. 1
Temporal Trends in the Use of Primary Prevention Medications at Stroke Admission
Introduction: Over 80% of strokes are preventable through appropriate management of cardiovascular risk factors including pharmacotherapy interventions (antihypertensive and lipid-lowering medications). In this study, we aimed to: (i) determine the proportion of patients reported to use primary prevention medications before their first stroke admission and (ii) compare differences in the use of these medications over time, by sex and age. Methods: For this study, we used secondary analysis of cross-sectional clinical data from the Stroke Foundation biennial National Stroke Audit – Acute Services (2007–2019; 7 cycles). Data collected for adult patients with first-ever stroke included demographics (age, sex), stroke presentation information (stroke type), and medical history (risk factors, use of primary prevention medications, pre-stroke independence [modified Rankin Scale]). Patient data were summarized with descriptive statistics. Adjusted proportions (year, age, sex, pre-stroke independence) of medication use were derived from multivariable logistic regression models. Proportions were compared across audit years using Cochran-Armitage tests for linear trends (ptrend) and analyzed by prespecified subgroups (men vs. women; aged <65 vs. ≥65 years). Results: Of 17,944 patients (median age 74.6 years; 54.5% male), most had a history of hypertension (73.0%), and 48.4% had hypercholesterolemia before stroke. Significant increases in the use of antihypertensive medications were observed over time, particularly for women (all ages ptrend = 0.004, 0.2% increase per cycle), especially women aged <65 years (ptrend = 0.006, 1.1% increase per cycle). There was an increase in the use of lipid-lowering medications for men (ptrend<0.001, 0.7% increase per cycle) and all patients aged <65 years (ptrend<0.001, 1.5% increase per cycle). Only men aged ≥65 years had an increase in the use of lipid-lowering medication over time (ptrend = 0.037, 0.4% increase per cycle). Conclusion: The use of primary prevention medications before first stroke increased over time in the audited stroke episodes from participating Australian hospitals. There were disparities across sex and age groups, indicating opportunities to improve equitable access to guideline-recommended care to enhance primary stroke prevention.
- 26 August 2026
- Published by S. Karger AG in Neuroepidemiology
- p. 1
Open AccessTemporal Trends in the Use of Primary Prevention Medications at Stroke Admission
Introduction: Over 80% of strokes are preventable through appropriate management of cardiovascular risk factors including pharmacotherapy interventions (antihypertensive and lipid-lowering medications). In this study, we aimed to: (i) determine the proportion of patients reported to use primary prevention medications before their first stroke admission and (ii) compare differences in the use of these medications over time, by sex and age. Methods: For this study, we used secondary analysis of cross-sectional clinical data from the Stroke Foundation biennial National Stroke Audit – Acute Services (2007–2019; 7 cycles). Data collected for adult patients with first-ever stroke included demographics (age, sex), stroke presentation information (stroke type), and medical history (risk factors, use of primary prevention medications, pre-stroke independence [modified Rankin Scale]). Patient data were summarized with descriptive statistics. Adjusted proportions (year, age, sex, pre-stroke independence) of medication use were derived from multivariable logistic regression models. Proportions were compared across audit years using Cochran-Armitage tests for linear trends (ptrend) and analyzed by prespecified subgroups (men vs. women; aged <65 vs. ≥65 years). Results: Of 17,944 patients (median age 74.6 years; 54.5% male), most had a history of hypertension (73.0%), and 48.4% had hypercholesterolemia before stroke. Significant increases in the use of antihypertensive medications were observed over time, particularly for women (all ages ptrend = 0.004, 0.2% increase per cycle), especially women aged <65 years (ptrend = 0.006, 1.1% increase per cycle). There was an increase in the use of lipid-lowering medications for men (ptrend<0.001, 0.7% increase per cycle) and all patients aged <65 years (ptrend<0.001, 1.5% increase per cycle). Only men aged ≥65 years had an increase in the use of lipid-lowering medication over time (ptrend = 0.037, 0.4% increase per cycle). Conclusion: The use of primary prevention medications before first stroke increased over time in the audited stroke episodes from participating Australian hospitals. There were disparities across sex and age groups, indicating opportunities to improve equitable access to guideline-recommended care to enhance primary stroke prevention.
- Open Access
- 25 February 2026
- Published by Springer Nature in Trials
- Vol. 27 (1)
Statistical analysis plan for Love Your Brain: a multi-arm randomised controlled trial of a stroke prevention digital platform
Background: Stroke is common, affecting an estimated one in four people in their lifetime. Fortunately, stroke is also highly preventable. With the rise in digital literacy and the increasing adoption of digital health tools, a promising avenue for stroke prevention is through digitally-delivered interventions. Love Your Brain: A stroke prevention digital platform is a three-year research project to develop and evaluate a digital platform to 1) increase participant visits to their medical practitioner for assessment or management of cardiovascular risk factors (primary outcome); and 2) improve participants’ health-related stroke knowledge, adherence to prevention medications and uptake of healthy or risk-modifying behaviour (secondary outcomes). The project is a multi-arm randomised controlled trial, comparing the common control arm to each of the intervention arms (either an online course or text messages). We present the statistical analysis plan for this trial. Methods/design: Participants are randomised 1:1:1 in variable block sizes, with stratification balancing by age and sex. The sample size of 894 participants was calculated to detect a 30% relative intervention effect, with 80% power and 5% significance level (two-sided). Recruitment will end when the sample size is achieved (adjusting for ≤ 10% attrition rate). The primary outcome will be compared separately for each intervention arm with the common control arm. As the outcome is binary, log-binomial regression models will be used with adjustment for stratification variables (i.e., gender, age groups [45–64 and >= 65 years]) and covariates that demonstrate imbalances between arms at baseline. Secondary outcomes will be evaluated using generalised mixed effects regression models (including linear, log-binomial, or quantile regression). The primary outcome analysis will be based on intention-to-treat. A p-value ≤ 0.05 will indicate statistical significance. Conclusions: This statistical analysis plan ensures transparency in reporting the trial outcomes. Love Your Brain will provide novel evidence on the effectiveness of two digital health education platforms for the prevention of stroke. Trial registration: ACTRN12625000124437; U1111-1305-2964 Feasibility Pilot: Australian New Zealand Clinical Trials Registry: ACTRN12624000540516; Universal Trial Number: U1111-1305-2964. SAP Version: 1.0 (September 2025) Protocol version: 1.0 (December, 2024) SAP revisions: Nil
- 25 February 2026
- Published by Springer Nature in Trials
- Vol. 27 (1)
Open AccessStatistical analysis plan for Love Your Brain: a multi-arm randomised controlled trial of a stroke prevention digital platform
Background: Stroke is common, affecting an estimated one in four people in their lifetime. Fortunately, stroke is also highly preventable. With the rise in digital literacy and the increasing adoption of digital health tools, a promising avenue for stroke prevention is through digitally-delivered interventions. Love Your Brain: A stroke prevention digital platform is a three-year research project to develop and evaluate a digital platform to 1) increase participant visits to their medical practitioner for assessment or management of cardiovascular risk factors (primary outcome); and 2) improve participants’ health-related stroke knowledge, adherence to prevention medications and uptake of healthy or risk-modifying behaviour (secondary outcomes). The project is a multi-arm randomised controlled trial, comparing the common control arm to each of the intervention arms (either an online course or text messages). We present the statistical analysis plan for this trial. Methods/design: Participants are randomised 1:1:1 in variable block sizes, with stratification balancing by age and sex. The sample size of 894 participants was calculated to detect a 30% relative intervention effect, with 80% power and 5% significance level (two-sided). Recruitment will end when the sample size is achieved (adjusting for ≤ 10% attrition rate). The primary outcome will be compared separately for each intervention arm with the common control arm. As the outcome is binary, log-binomial regression models will be used with adjustment for stratification variables (i.e., gender, age groups [45–64 and >= 65 years]) and covariates that demonstrate imbalances between arms at baseline. Secondary outcomes will be evaluated using generalised mixed effects regression models (including linear, log-binomial, or quantile regression). The primary outcome analysis will be based on intention-to-treat. A p-value ≤ 0.05 will indicate statistical significance. Conclusions: This statistical analysis plan ensures transparency in reporting the trial outcomes. Love Your Brain will provide novel evidence on the effectiveness of two digital health education platforms for the prevention of stroke. Trial registration: ACTRN12625000124437; U1111-1305-2964 Feasibility Pilot: Australian New Zealand Clinical Trials Registry: ACTRN12624000540516; Universal Trial Number: U1111-1305-2964. SAP Version: 1.0 (September 2025) Protocol version: 1.0 (December, 2024) SAP revisions: Nil
- Open Access
- 19 January 2026
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 40 (6) , 827-842
Comparing inpatient stroke rehabilitation care and outcomes for people with and without aphasia in Australia
Objective: To investigate whether presence of aphasia is associated with differences in inpatient stroke rehabilitation care and outcomes. Design: Observational study of cross-sectional data from hospitals participating in the biennial National Stroke Audit – Rehabilitation Services (Stroke Foundation, 2016, 2018 and 2020). Descriptive statistics and multi-level multi-variable logistic regression were used to examine associations between aphasia status, processes of care, and patient outcomes, with level defined as hospital. Setting: Australian inpatient rehabilitation hospitals. Participants: All patients with stroke who had aphasia status recorded. Main measures: Adherence to processes of care recommended in the Australian and New Zealand Clinical Guidelines for Stroke Management. In-hospital outcomes included complications, independence, survival, and discharge destination. Results: Overall, 9960 audits were included; 3160 (33%) patients had aphasia (56% male; median age 75; no aphasia: 56% male; median age 76). Patients with aphasia were more likely to have a mood impairment (54% vs. 44%) and less likely to be assessed by a psychologist (40% vs. 49%). Fewer patients with aphasia were involved in goal setting (84% vs. 88%) or development of care plans (91% vs. 96%); or asked about returning to work (67% vs. 74%) or driving (41% vs. 45%). Patients with aphasia had a longer length of stay (median 26 vs. 21 days, p≤0.001) and were less independent on discharge (adjusted odds ratio (aOR) 0.80, 95% CI 0.71, 0.90). Conclusions: Identified differences in stroke rehabilitation highlight the need for equitable access to care and effective patient-provider communication enabling people with aphasia to more fully participate in their rehabilitation.
- 19 January 2026
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 40 (6) , 827-842
Open AccessComparing inpatient stroke rehabilitation care and outcomes for people with and without aphasia in Australia
Objective: To investigate whether presence of aphasia is associated with differences in inpatient stroke rehabilitation care and outcomes. Design: Observational study of cross-sectional data from hospitals participating in the biennial National Stroke Audit – Rehabilitation Services (Stroke Foundation, 2016, 2018 and 2020). Descriptive statistics and multi-level multi-variable logistic regression were used to examine associations between aphasia status, processes of care, and patient outcomes, with level defined as hospital. Setting: Australian inpatient rehabilitation hospitals. Participants: All patients with stroke who had aphasia status recorded. Main measures: Adherence to processes of care recommended in the Australian and New Zealand Clinical Guidelines for Stroke Management. In-hospital outcomes included complications, independence, survival, and discharge destination. Results: Overall, 9960 audits were included; 3160 (33%) patients had aphasia (56% male; median age 75; no aphasia: 56% male; median age 76). Patients with aphasia were more likely to have a mood impairment (54% vs. 44%) and less likely to be assessed by a psychologist (40% vs. 49%). Fewer patients with aphasia were involved in goal setting (84% vs. 88%) or development of care plans (91% vs. 96%); or asked about returning to work (67% vs. 74%) or driving (41% vs. 45%). Patients with aphasia had a longer length of stay (median 26 vs. 21 days, p≤0.001) and were less independent on discharge (adjusted odds ratio (aOR) 0.80, 95% CI 0.71, 0.90). Conclusions: Identified differences in stroke rehabilitation highlight the need for equitable access to care and effective patient-provider communication enabling people with aphasia to more fully participate in their rehabilitation.
- Open Access
- 1 January 2026
- Published by SAGE Publications in Health Information Management Journal
- Vol. 55 (1) , 3-7
The intersection of health information management and clinical registries
- 1 January 2026
- Published by SAGE Publications in Health Information Management Journal
- Vol. 55 (1) , 3-7
Open AccessThe intersection of health information management and clinical registries
- Open Access
- 21 October 2025
- Published by Wiley in Health Expectations
- Vol. 28 (5) , e70471
Development of a Health Text Message System to Support Stroke Prevention: A Component of the Love Your Brain Digital Platform
Objectives: Globally, stroke is a common cause of death and disability. More than 80% of strokes are reported to be preventable through effective management of modifiable risk factors. Text messages can encourage changes in health behaviour. The Love Your Brain project involves the development and evaluation of a digital health platform for stroke prevention in Australia. In this study, we aimed to develop a text message system and content for this digital platform. Method: The first phase involved reviewing a repository of existing health promotion messages from prior research on stroke. The second phase included co‐designing the content and delivery of the messaging system with community members ( n = 12) and health knowledge experts ( n = 10) through 16 focus groups. New messages were then developed and formatted. These messages were reviewed by subject matter experts, then adjusted for reading age ≤ Grade 10. The final phase included the development of the messaging platform. Results: Among 1500+ pre‐existing messages reviewed for suitability, ≈10% were adapted for primary prevention. Focus group participants reported that receiving messages on weekdays was preferred and ‘ having a choice’ was beneficial. No consensus was reached regarding message frequency. Weblinks and shorteners were felt to be untrustworthy by participants; therefore, a Love Your Brain website using one hyperlink was developed. New messages were co‐designed and personalised with greetings and sign‐offs to increase engagement. All messages were revised by at least three of eight experts. After editing, 98% were readable at ≤ Grade 10 reading age and 79% at ≤ Grade 8. A REDCap message platform was built to enable personalisation at any time regarding the selection of ‘healthy choices’ relevant to participants' risk factors and preferences for the number of messages per week. Conclusion: Integrating prior research and co‐design enriched the text message platform, including content and delivery. This system can be adapted for other conditions and cultural needs to deliver relevant health information. Patient or Public Contribution: People with lived experience of stroke including family/caregivers. and members of the public, actively participated in the co‐design focus groups. The Love Your Brain Management Committee includes people with lived experience of stroke who work in partnership with researchers and clinicians to provide oversight of all stages of the study and the preparation of this manuscript.
- 21 October 2025
- Published by Wiley in Health Expectations
- Vol. 28 (5) , e70471
Open AccessDevelopment of a Health Text Message System to Support Stroke Prevention: A Component of the Love Your Brain Digital Platform
Objectives: Globally, stroke is a common cause of death and disability. More than 80% of strokes are reported to be preventable through effective management of modifiable risk factors. Text messages can encourage changes in health behaviour. The Love Your Brain project involves the development and evaluation of a digital health platform for stroke prevention in Australia. In this study, we aimed to develop a text message system and content for this digital platform. Method: The first phase involved reviewing a repository of existing health promotion messages from prior research on stroke. The second phase included co‐designing the content and delivery of the messaging system with community members ( n = 12) and health knowledge experts ( n = 10) through 16 focus groups. New messages were then developed and formatted. These messages were reviewed by subject matter experts, then adjusted for reading age ≤ Grade 10. The final phase included the development of the messaging platform. Results: Among 1500+ pre‐existing messages reviewed for suitability, ≈10% were adapted for primary prevention. Focus group participants reported that receiving messages on weekdays was preferred and ‘ having a choice’ was beneficial. No consensus was reached regarding message frequency. Weblinks and shorteners were felt to be untrustworthy by participants; therefore, a Love Your Brain website using one hyperlink was developed. New messages were co‐designed and personalised with greetings and sign‐offs to increase engagement. All messages were revised by at least three of eight experts. After editing, 98% were readable at ≤ Grade 10 reading age and 79% at ≤ Grade 8. A REDCap message platform was built to enable personalisation at any time regarding the selection of ‘healthy choices’ relevant to participants' risk factors and preferences for the number of messages per week. Conclusion: Integrating prior research and co‐design enriched the text message platform, including content and delivery. This system can be adapted for other conditions and cultural needs to deliver relevant health information. Patient or Public Contribution: People with lived experience of stroke including family/caregivers. and members of the public, actively participated in the co‐design focus groups. The Love Your Brain Management Committee includes people with lived experience of stroke who work in partnership with researchers and clinicians to provide oversight of all stages of the study and the preparation of this manuscript.
- Open Access
- 13 June 2025
- Published by SAGE Publications in Health Information Management Journal
- Vol. 55 (1) , 51-59
Exploration of the role of health information managers in the world of clinical registries
Background: There is increased demand for health information managers (HIMs) to work at clinical registries. Objective: To explore and describe the (i) roles and responsibilities of HIMs and (ii) reported HIM workforce within Australian clinical registries. Method: Two cross-sectional surveys were undertaken with qualified HIMs and data custodians. Respondents were engaged through snowballing methods. Descriptive statistics were used to summarise quantitative data from both surveys. Inductive thematic analysis was used to summarise free-text responses. Results: Sixteen HIMs completed the survey (94% female; 50% aged use more of [their] health information management skills .” From 27 responses to the data custodian survey, 12 employed HIMs and demonstrated a good understanding of their skills, which aligned with responses to the HIM survey. There was a gap identified in database management and analysis skills (n = 4) at clinical registries that do not employ HIMs. Conclusion: HIMs play an important role within clinical registries, especially related to data management, analysis and reporting. Ongoing advocacy is required to increase the understanding of HIMs’ skills and to increase the responsibilities and number of HIMs working at clinical registries. Implications for health information management practice: HIMs are well-positioned to contribute to Australian clinical registries.
- 13 June 2025
- Published by SAGE Publications in Health Information Management Journal
- Vol. 55 (1) , 51-59
Open AccessExploration of the role of health information managers in the world of clinical registries
Background: There is increased demand for health information managers (HIMs) to work at clinical registries. Objective: To explore and describe the (i) roles and responsibilities of HIMs and (ii) reported HIM workforce within Australian clinical registries. Method: Two cross-sectional surveys were undertaken with qualified HIMs and data custodians. Respondents were engaged through snowballing methods. Descriptive statistics were used to summarise quantitative data from both surveys. Inductive thematic analysis was used to summarise free-text responses. Results: Sixteen HIMs completed the survey (94% female; 50% aged use more of [their] health information management skills .” From 27 responses to the data custodian survey, 12 employed HIMs and demonstrated a good understanding of their skills, which aligned with responses to the HIM survey. There was a gap identified in database management and analysis skills (n = 4) at clinical registries that do not employ HIMs. Conclusion: HIMs play an important role within clinical registries, especially related to data management, analysis and reporting. Ongoing advocacy is required to increase the understanding of HIMs’ skills and to increase the responsibilities and number of HIMs working at clinical registries. Implications for health information management practice: HIMs are well-positioned to contribute to Australian clinical registries.
- Open Access
- 22 May 2025
- Published by Wiley in Health Expectations
- Vol. 28 (3) , e70272
Processes Underpinning Successful Co‐Design: Lessons From a Digital Health Project
Background: Co‐design helps to align research with end‐user needs, but there is no consistent method for reporting co‐design methodology and evaluation. We share our experiences co‐designing the Love Your Brain digital platform for stroke prevention. We evaluated the core attributes that guided our co‐design approach, including recruitment, focus group coordination, participant engagement and satisfaction. Methods: Online co‐design focus groups were conducted fortnightly (May 2023 to March 2024) with two cohorts (health knowledge experts and community members; n = 8 sessions per cohort) to design the content and structure of Love Your Brain. Snowballing methods and purposive sampling were used to recruit participants in Australia. Coordination involved tracking the time spent by the research team for one round of focus groups. Participant engagement was measured through focus group attendance and survey feedback and analysed using descriptive statistics and thematic analysis. Count and length of verbal and/or written contributions during focus groups were summarised with descriptive statistics as a measure of engagement, with differences between cohorts assessed using χ 2 /Wilcoxon rank‐sum tests. Participant satisfaction was evaluated using survey responses and input at a final evaluative focus group. Results: Sixteen health knowledge experts (clinicians/researchers) and 28 community members expressed interest, of which 10 health knowledge experts and 12 community members (including 9 people with lived experience of stroke) participated. Conducting two identical focus groups required 29 h of project manager/coordinator time, 8–11 h for facilitators and 6.5–8.5 h for chief investigators. Most participants (86%) attended ≥ 5/8 focus groups. Engagement was enhanced through pre‐reading material, structured/well‐organised focus groups and experienced facilitators. All participants contributed at each focus group, with varying levels of input. Health knowledge experts preferred written contributions over verbal contributions and wrote longer messages compared to community members. Community members spoke for a longer duration than health knowledge experts. Participant satisfaction was high, with participants reporting that the research team ‘always valued our opinions’. Importance was placed on a final evaluative focus group, and participants stated that their contributions were incorporated into the final product. Conclusion: Our research emphasises relationships between coordination, participant engagement and satisfaction and the importance of considering resourcing requirements for successful co‐design of digital health projects. Patient or Public Contribution: People with lived experience, including caregivers of people with stroke, and members of the public, participated in the co‐design focus groups. The Love Your Brain Management Committee includes people with lived experience of stroke who contributed to the oversight of this study and the preparation of this manuscript.
- 22 May 2025
- Published by Wiley in Health Expectations
- Vol. 28 (3) , e70272
Open AccessProcesses Underpinning Successful Co‐Design: Lessons From a Digital Health Project
Background: Co‐design helps to align research with end‐user needs, but there is no consistent method for reporting co‐design methodology and evaluation. We share our experiences co‐designing the Love Your Brain digital platform for stroke prevention. We evaluated the core attributes that guided our co‐design approach, including recruitment, focus group coordination, participant engagement and satisfaction. Methods: Online co‐design focus groups were conducted fortnightly (May 2023 to March 2024) with two cohorts (health knowledge experts and community members; n = 8 sessions per cohort) to design the content and structure of Love Your Brain. Snowballing methods and purposive sampling were used to recruit participants in Australia. Coordination involved tracking the time spent by the research team for one round of focus groups. Participant engagement was measured through focus group attendance and survey feedback and analysed using descriptive statistics and thematic analysis. Count and length of verbal and/or written contributions during focus groups were summarised with descriptive statistics as a measure of engagement, with differences between cohorts assessed using χ 2 /Wilcoxon rank‐sum tests. Participant satisfaction was evaluated using survey responses and input at a final evaluative focus group. Results: Sixteen health knowledge experts (clinicians/researchers) and 28 community members expressed interest, of which 10 health knowledge experts and 12 community members (including 9 people with lived experience of stroke) participated. Conducting two identical focus groups required 29 h of project manager/coordinator time, 8–11 h for facilitators and 6.5–8.5 h for chief investigators. Most participants (86%) attended ≥ 5/8 focus groups. Engagement was enhanced through pre‐reading material, structured/well‐organised focus groups and experienced facilitators. All participants contributed at each focus group, with varying levels of input. Health knowledge experts preferred written contributions over verbal contributions and wrote longer messages compared to community members. Community members spoke for a longer duration than health knowledge experts. Participant satisfaction was high, with participants reporting that the research team ‘always valued our opinions’. Importance was placed on a final evaluative focus group, and participants stated that their contributions were incorporated into the final product. Conclusion: Our research emphasises relationships between coordination, participant engagement and satisfaction and the importance of considering resourcing requirements for successful co‐design of digital health projects. Patient or Public Contribution: People with lived experience, including caregivers of people with stroke, and members of the public, participated in the co‐design focus groups. The Love Your Brain Management Committee includes people with lived experience of stroke who contributed to the oversight of this study and the preparation of this manuscript.
- Open Access
- 22 May 2025
- Published by Wiley in Health Expectations
- Vol. 28 (3) , e70293
Co‐Designing a Digital Stroke Prevention Platform: Leveraging Lived Experience and Expert Advice
Background: The majority of strokes are preventable through effective risk factor management. Existing primary prevention strategies have insufficient reach and effectiveness. Digital health technologies offer the potential to overcome some of these barriers. The aim of this study was to co‐design the ‘Love Your Brain’ digital platform, including an online education program (Massive Open Online Course, MOOC) and text messaging system, for community stroke prevention education and management. Methods: Using snowballing methods, expressions of interest were sought from community members and health knowledge experts (e.g., health professionals and researchers) from across Australia. Participants were purposively selected for diversity in age, sex, location, education (community) and profession (health knowledge experts). A series of eight focus groups were planned. From May 2023 to August 2023, seven online focus groups were undertaken separately with each cohort, to explore perceptions related to the core functions, content and design features. Their insights were used to develop the digital platform. Following a testing period, a final focus group was held with each cohort (March 2024) to evaluate the digital platform further. Focus groups were recorded with participant consent. Recordings and transcripts, live chats and interactive polls from the focus groups were analysed using inductive and deductive thematic approaches, with themes mapped to the Framework for the Design and Evaluation of MOOCs. Results: Twelve community members and ten health knowledge experts participated in at least one of the eight focus groups, with overall 86% attending five or more. Although some diversity existed in group opinions about the delivery and content, all participants emphasised the importance of using simple, easy‐to‐understand language and layout throughout, with the inclusion of a variety of statistics, personal stories and expert information. Focusing on emotional motivation was perceived as essential for engagement with the digital platform. Furthermore, being able to personalise the content and provide options for people to explore more advanced information (via external resources and a project‐specific website with trusted links) was considered advantageous. Conclusion: Co‐design with community and knowledge expert cohorts informed and enriched the development of the Love Your Brain digital platform. The co‐designed platform is currently being piloted in a feasibility trial. Patient or Public Contribution: People with lived experience of stroke, along with family/caregivers and members of the public, actively participated in the co‐design focus groups. The Love Your Brain Management Committee comprises lived experience stroke survivors and carers who worked in partnership with researchers and clinicians to provide oversight and guidance to the development and implementation of all stages of the study, including the preparation of this manuscript.
- 22 May 2025
- Published by Wiley in Health Expectations
- Vol. 28 (3) , e70293
Open AccessCo‐Designing a Digital Stroke Prevention Platform: Leveraging Lived Experience and Expert Advice
Background: The majority of strokes are preventable through effective risk factor management. Existing primary prevention strategies have insufficient reach and effectiveness. Digital health technologies offer the potential to overcome some of these barriers. The aim of this study was to co‐design the ‘Love Your Brain’ digital platform, including an online education program (Massive Open Online Course, MOOC) and text messaging system, for community stroke prevention education and management. Methods: Using snowballing methods, expressions of interest were sought from community members and health knowledge experts (e.g., health professionals and researchers) from across Australia. Participants were purposively selected for diversity in age, sex, location, education (community) and profession (health knowledge experts). A series of eight focus groups were planned. From May 2023 to August 2023, seven online focus groups were undertaken separately with each cohort, to explore perceptions related to the core functions, content and design features. Their insights were used to develop the digital platform. Following a testing period, a final focus group was held with each cohort (March 2024) to evaluate the digital platform further. Focus groups were recorded with participant consent. Recordings and transcripts, live chats and interactive polls from the focus groups were analysed using inductive and deductive thematic approaches, with themes mapped to the Framework for the Design and Evaluation of MOOCs. Results: Twelve community members and ten health knowledge experts participated in at least one of the eight focus groups, with overall 86% attending five or more. Although some diversity existed in group opinions about the delivery and content, all participants emphasised the importance of using simple, easy‐to‐understand language and layout throughout, with the inclusion of a variety of statistics, personal stories and expert information. Focusing on emotional motivation was perceived as essential for engagement with the digital platform. Furthermore, being able to personalise the content and provide options for people to explore more advanced information (via external resources and a project‐specific website with trusted links) was considered advantageous. Conclusion: Co‐design with community and knowledge expert cohorts informed and enriched the development of the Love Your Brain digital platform. The co‐designed platform is currently being piloted in a feasibility trial. Patient or Public Contribution: People with lived experience of stroke, along with family/caregivers and members of the public, actively participated in the co‐design focus groups. The Love Your Brain Management Committee comprises lived experience stroke survivors and carers who worked in partnership with researchers and clinicians to provide oversight and guidance to the development and implementation of all stages of the study, including the preparation of this manuscript.